Economic Burden of Legionnaires’ Disease, United States, 2014
- 1 January 2021
- journal article
- research article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 27 (1) , 255-257
Abstract
Through the use of published estimates of medical costs and new calculations of productivity losses, we estimate the lifetime economic burden of 2014 Legionnaires’ disease cases in the United States at ≈$835 million. This total includes $21 million in productivity losses caused by absenteeism and $412 million in productivity losses caused by premature deaths.Keywords
This publication has 5 references indexed in Scilit:
- Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United StatesEmerging Infectious Diseases, 2021
- Vital Signs: Deficiencies in Environmental Control Identified in Outbreaks of Legionnaires’ Disease — North America, 2000–2014MMWR. Morbidity and Mortality Weekly Report, 2016
- Active Bacterial Core Surveillance for Legionellosis — United States, 2011–2013MMWR. Morbidity and Mortality Weekly Report, 2015
- Measuring and valuing productivity loss due to poor health: A critical reviewSocial Science & Medicine, 2011
- Economic Productivity by Age and SexMedical Care, 2009